Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Free Cash Flow: 2019-2024

Historic Free Cash Flow for LifeStance Health (LFST) over the last 5 years, with FY2024 value amounting to $85.7 million.

  • LifeStance Health's Free Cash Flow fell 381.98% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.4 million, marking a year-over-year increase of 24053.62%. This contributed to the annual value of $85.7 million for FY2024, which is 24928.23% up from last year.
  • As of FY2024, LifeStance Health's Free Cash Flow stood at $85.7 million, which was up 24928.23% from -$57.4 million recorded in FY2023.
  • Over the past 5 years, LifeStance Health's Free Cash Flow peaked at $85.7 million during FY2024, and registered a low of -$85.1 million during FY2021.
  • In the last 4 years, LifeStance Health's Free Cash Flow had a median value of -$41.9 million in 2022 and averaged -$20.8 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first crashed by 11689.72% in 2023, then soared by 24928.23% in 2024.
  • Annual analysis of 4 years shows LifeStance Health's Free Cash Flow stood at -$85.1 million in 2021, then skyrocketed by 68.89% to -$26.5 million in 2022, then plummeted by 116.9% to -$57.4 million in 2023, then surged by 249.28% to $85.7 million in 2024.
  • Its last three reported values are $85.7 million in FY2024, -$57.4 million for FY2023, and -$26.5 million during FY2022.